Alvotech And Fuji Pharma Broaden Biosimilar Alliance In Japan

Number Of New Candidates Added To Partnership

Longtime partners Alvotech and Fuji Pharma – the latter being a minority shareholder in the Icelandic firm – have extended their existing biosimilars partnership in Japan, as Alvotech continues to make strategic moves across the globe.

Japanese flag
Fuji Pharma now boasts "an industry-leading biosimilar pipeline." • Source: Shutterstock

More from Biosimilars

More from Products